Rethinking Go-to-Market From the Ground Up

Run Time

10 minutes

AI is transforming how pharmaceutical companies approach go-to-market strategy, HCP engagement, and field team performance. But with new capabilities comes a critical question: What’s actually changing, and what’s just hype?

In the debut episode of Open Label, Norstella’s AI podcast for pharma, host Kris Kaneta is joined by Omar Lansari of Citius Oncology and Allison Perry of Norstella to explore how AI-powered insights and real-world data are helping commercial teams make smarter decisions, personalize provider engagement, and navigate the evolving pharmaceutical landscape.

Discover why successful AI adoption isn’t about replacing proven strategies, but enhancing them with better data, deeper insights, and more informed decision-making.

Frequently asked questions

How is AI transforming pharma go-to-market strategies?
AI is helping pharmaceutical companies analyze larger volumes of data, identify target audiences, and personalize engagement strategies. While core marketing principles remain the same, AI enables commercial teams to make faster, more informed decisions and optimize their go-to-market execution.
How does AI improve healthcare provider (HCP) engagement?
AI enables pharma teams to combine real-world data, claims information, and clinical insights to better understand HCP behavior and patient needs. These insights help commercial teams deliver more relevant messaging, identify engagement opportunities, and build stronger provider relationships.
What role does real-world data play in AI-powered pharma marketing?
Real-world data provides the foundation for AI-driven commercial insights. By analyzing claims, electronic health records, and other healthcare data sources, pharmaceutical companies can better identify patient populations, understand treatment patterns, and improve commercial targeting.
How is AI changing the role of pharmaceutical sales representatives?
AI equips pharmaceutical sales representatives with deeper territory insights, more precise targeting information, and opportunities for personalized HCP interactions. Rather than replacing sales representatives, AI supports their ability to make informed decisions and strengthen face-to-face engagement.
Daniel-Chancellor
Dan Chancellor
VP, Thought Leadership, Norstella
madeline-naylor-headshot
Dr. Madeline Naylor, DHSc, MMS, CCRP
Chief Clinician, Norstella
lance-wolkenbrod-headshot
Lance Wolkenbrod
Senior Principal, Real-World Data Solutions, Norstella

Norstella Brands